About
Guillem Laporta makes and manages investments at Ysios Capital and handles investor reporting. He has 15 years of venture capital experience and previously worked at the Edmond de Rothschild Group (now Andera Partners) in Paris, where he was involved in investments across Europe and the United States, including Reviral, Axonics Modulation, Sanifit and Verona Pharma. He is a CFA charterholder and holds bachelor's degrees in Biotechnology from the Universitat Autonoma de Barcelona and in Business Administration from the Universitat Pompeu Fabra.
Invests in
Biotech
Experience
- Ysios CapitalPartnercurrent2018 — presentBarcelona Area, Spain
- Andera PartnersLife Sciences Investment Associate2013 — 2018Paris Area, France
- Caixa Capital RiscLife Sciences Investment Analyst2012 — 2013Barcelona Area, Spain
Education
- Universitat Autònoma de BarcelonaGraduate, Biotechnology2009 — 2013
- University of VirginiaFellowship, Biotechnology2011
- Universitat Pompeu FabraGraduate, Business Administration2005 — 2009
Skills & more
Market Research11Venture Capital10Investments13Business Strategy9Marketing Strategy5Entrepreneurship14Biotechnology17Business Planning7Management Consulting6Lifesciences3Start-ups5Life Sciences7
+7 more
Portfolio ManagementValuationPrivate EquityEnglishSpanishNegotiationTeamworkLanguages Catalan · English · French · Spanish
- Chartered Financial Analyst (CFA) — CFA Institute
From Guillem's professional profile.
Same school
Also attended Universitat Autònoma de Barcelona58
Eduard FeliuManaging Partner at Inveready Technology Investment GroupMar FernándezMarketing & Communications Manager at Inveready Technology Investment GroupAgustina NietoLegal Counsel at Nauta CapitalIsabel JimenezPrincipal at Asabys PartnersLaura ArgelichAssociate at Ysios CapitalBen ScheidtPartner at Redstone
+ 52 more
Also attended University of Virginia316
Alexis OhanianFounder & General Partner of Seven Seven SixAndy FligelSenior Managing Director at Intel CapitalKandace ElamVice President of GTM Talent at Menlo VenturesTrevor KienzleInvestor at Correlation VenturesFrank RotmanCo-Founder and Partner Emeritus at QED InvestorsMegan LightcapPartner, Creator Fund at Slow Ventures
+ 310 more
Also attended Universitat Pompeu Fabra59
Aniol BrosaGeneral Partner at Inveready Technology Investment GroupErnest GassóDirector at Inveready Technology Investment GroupAgustina NietoLegal Counsel at Nauta CapitalJosep Ll. SanfeliuCo-founder and managing partner at Asabys PartnersGuillem MasferrerPartner at Asabys PartnersMontse VendrellPartner at Asabys Partners
+ 53 more
Shared employers
Also worked at Andera Partners31
Olivier Le GallPartner at Andera PartnersLéopold BrichardPartner at Andera PartnersMayeul CaronPartner at Andera PartnersRémi SpagnolPartner at Supernova InvestOlivier LitzkaPartner at Andera PartnersSofia IoannidouPartner at Andera Partners
+ 25 more
Also worked at Caixa Capital Risc17
Maria PovedaDirector at Inveready Technology Investment GroupGuillem MasferrerPartner at Asabys PartnersJesús MonleónManaging Partner at 4Founders CapitalCarlos EstebanPartner at FaberMilós EstevaPortfolio Manager at Criteria Venture TechGina CodoniInvestment Analyst at Criteria Venture Tech
+ 11 more
Investments
Board seats
Engrail TherapeuticsKynexisReproNovoVarmX
Per the firm's website.
Colleagues at Ysios Capital
Almudena Méndez
Associate at Ysios Capital
Antoni Ribas
Venture Partner at Ysios Capital
Arturo Urrios
Partner at Ysios Capital
Carlos Garcia-Echeverria
Venture Partner at Ysios Capital
Carlos Paya
Venture Partner at Ysios Capital
Catalina Cuchy
Executive Assistant at Ysios Capital
Cristina Garmendia
General Partner at Ysios Capital
David L. Lacey
Venture Partner at Ysios Capital